Council on the Kidney in Cardiovascular Disease (KCVD)
Message from the Chair@Model.Item.RenderHeadingSizeTag("h2")>
Welcome to the Council for the Kidney in Cardiovascular Disease (KCVD). Our Council strives to reduce cardiovascular-related disability and death through clinical, translational, and basic research, communication, advocacy and education relevant to: a) the role of the kidney in hypertension, b) the role of the kidney in cardiovascular diseases – this includes acute kidney injury and chronic kidney disease and its effects on heart disease, stroke, and peripheral vascular disease, c) the specific role of the kidney in diabetes-induced cardiovascular disease, and d) cardio-renal syndrome.
Alexander Staruschenko, PhD, FAHA
Chair, Council on Kidney in Cardiovascular Disease
News and Information from the KCVD Council
Hypertension Scientific Sessions 2021Sept. 27–29, 2021
A Virtual Event
Scientific Sessions 2021
November 13-15, 2021
Boston, MA + Virtual
AHA Professional Members are Difference Makers @Model.Item.RenderHeadingSizeTag("h2")>
Funding Opportunities @Model.Item.RenderHeadingSizeTag("h2")>
The method for applying for funding is Web-based, using our electronic system, ProposalCentral.
Hypertension is one of 11 AHA journals. It represents the Councils on HBPR and KCVD, in cooperation with the Inter-American Society of Hypertension.